[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
A
A
Afshar-Oromieh
U
U
Haberkorn
M
M
Eder
M
M
Eisenhut
C M
CM
Zechmann
D000368:Aged; D000954:Antigens, Surface / Q000378:metabolism*; D002794:Choline / Q000031:analogs & derivatives*; D004492:Edetic Acid / Q000031:analogs & derivatives*; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D043425:Glutamate Carboxypeptidase II / Q000378:metabolism*; D006801:Humans; D007553:Isotope Labeling; D008024:Ligands; D008297:Male; D009842:Oligopeptides; D049268:Positron-Emission Tomography / Q000379:methods*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000503:physiopathology; D011849:Radioactive Tracers
D000954:Antigens, Surface; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D008024:Ligands; D009842:Oligopeptides; D011849:Radioactive Tracers; C000718244:gallium 68 PSMA-11; C448902:fluoroethylcholine; D004492:Edetic Acid; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II; D002794:Choline